首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
【2h】

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

机译:用微量滴定液稀释法进行酵母敏感性测试并通过临床结果验证。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is no ideal laboratory procedure or culture medium in current use for susceptibility testing of pathogenic yeasts. Six candidate growth media (RPMI 1640 with L-glutamine, yeast nitrogen base, Casamino Acids medium, Mueller-Hinton broth, Sabouraud dextrose broth, and minimum essential medium-Eagle salts) were screened by spectrophotometric absorbance for nucleic acid and protein. From these, two media were selected: a chemically defined growth medium (RPMI 1640 with L-glutamine) and a chemically complex medium (Casamino Acids). MICs of four antifungal agents (5-fluorocytosine, miconazole, ketoconazole, and amphotericin B) for 84 clinical isolates of various Candida species were then determined with both media in agar dilution and microtiter broth dilution systems. The resultant MICs were correlated with clinical outcome for those isolates obtained from patients treated with single antifungal agents, and susceptibility cut points were calculated. Derived MIC cut points for susceptibility were validated in a murine model of systemic candidiasis. RPMI 1640 with L-glutamine was found to have the lowest absorbance values for both nucleic acid and protein, while Casamino Acids medium was highest in both categories. We found that RPMI 1640 with L-glutamine was superior to Casamino Acids medium in the yield of MICs which correlated with actual clinical and animal outcome data. While there were no significant differences in MICs when RPMI 1640 medium was used, the microtiter broth dilution technique was superior to agar dilution in efficiency and ease of performance. We conclude that a microtiter broth system containing RPMI 1640 medium with L-glutamine is a simple, precise, and economical technique for susceptibility testing of pathogenic Candida species. We also suggest that the validation of susceptibility cut points with patient and animal outcome data make this microtiter broth system a preferential method for yeast susceptibility testing.
机译:当前没有用于病原酵母敏感性测试的理想的实验室程序或培养基。通过分光光度法对核酸和蛋白质进行分光光度筛选,筛选出六种候选生长培养基(具有L-谷氨酰胺的RPMI 1640,酵母氮碱基,Casamino Acids培养基,Mueller-Hinton肉汤,Sabouraud右旋糖肉汤和最低必需培养基-Eagle盐)。从中选择两种培养基:化学成分确定的生长培养基(带有L-谷氨酰胺的RPMI 1640)和化学成分复杂的培养基(卡西氨基酸)。然后使用琼脂稀释液和微量滴定液稀释系统中的两种培养基测定四种抗真菌药(5-氟胞嘧啶,咪康唑,酮康唑和两性霉素B)对84种不同念珠菌临床分离株的MIC。从使用单一抗真菌剂治疗的患者中分离出的分离株,所得MIC与临床结果相关,并计算了敏感性分界点。在系统性念珠菌病的小鼠模型中验证了敏感性的衍生MIC切割点。发现带有L-谷氨酰胺的RPMI 1640对核酸和蛋白质的吸光度值最低,而Casamino Acids介质在这两种类别中均最高。我们发现含L-谷氨酰胺的RPMI 1640在MIC的产量方面优于Casamino Acids培养基,而MIC与实际的临床和动物结果数据相关。尽管使用RPMI 1640培养基时MIC没有显着差异,但微量滴定液稀释技术的效率和易用性均优于琼脂稀释。我们得出的结论是,包含带有L-谷氨酰胺的RPMI 1640培养基的微量滴定肉汤系统是一种简单,精确且经济的技术,用于致病性念珠菌物种的药敏试验。我们还建议用患者和动物结果数据验证敏感性切点,使这种微量滴定液系统成为酵母敏感性测试的首选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号